Wikidata

(Q33344254)

English

Subsequent chemotherapy regimens are well tolerated after radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for non-Hodgkin's lymphoma

scientific article

In more languages

Statements

title
Subsequent chemotherapy regimens are well tolerated after radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for non-Hodgkin's lymphoma (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12228209
retrieved
26 July 2017
author name string
Stephen M Ansell
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
12228209
retrieved
26 July 2017
Kay M Ristow
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
12228209
retrieved
26 July 2017
Thomas M Habermann
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
12228209
retrieved
26 July 2017
Gregory A Wiseman
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
12228209
retrieved
26 July 2017
Thomas E Witzig
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
12228209
retrieved
26 July 2017
publication date
1 September 2002
1 reference
stated in
Europe PubMed Central
PubMed ID
12228209
retrieved
26 July 2017
page(s)
3885-3890
1 reference
stated in
Europe PubMed Central
PubMed ID
12228209
retrieved
26 July 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q33344254&oldid=1536749202"